Grove Bank & Trust Abb Vie Inc. Transaction History

Grove Bank & Trust

$670 Million
Q3 2024

A detailed history of Grove Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 12,859 shares of ABBV stock, worth $2.31 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

12,859

Previous 12,710 1.17%

Holding current value

$2.31 Million

Previous $2.18 Million 16.47%

% of portfolio

0.38%

Previous 0.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$163.84 - $199.33 $24,412 - $29,700	149 Added 1.17%	12,859 $2.54 Million
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $23,063 - $26,933	-149 Reduced 1.16%	12,710 $2.18 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $617,384 - $703,452	-3,863 Reduced 23.1%	12,859 $2.34 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $33,849 - $38,122	246 Added 1.49%	16,722 $2.59 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $98,188 - $113,667	735 Added 4.67%	16,476 $2.46 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $129,329 - $160,942	-976 Reduced 5.84%	15,741 $2.12 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $37,453 - $43,133	259 Added 1.57%	16,717 $2.66 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $445,773 - $534,599	-3,223 Reduced 16.38%	16,458 $2.66 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $225,204 - $258,294	-1,678 Reduced 7.86%	19,681 $2.64 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $164,455 - $209,077	-1,195 Reduced 5.3%	21,359 $3.27 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $117,990 - $146,392	894 Added 4.13%	22,554 $3.66 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $8,916 - $11,282	-83 Reduced 0.38%	21,660 $2.93 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $19,258 - $21,861	181 Added 0.84%	21,743 $2.35 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $82,063 - $91,423	780 Added 3.75%	21,562 $2.43 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $920 - $1,013	9 Added 0.04%	20,782 $2.25 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $93,448 - $126,165	1,161 Added 5.92%	20,773 $2.23 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $187,283 - $219,809	-2,180 Reduced 10.0%	19,612 $1.72 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $161,047 - $215,505	2,195 Added 11.2%	21,792 $2.14 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $55,212 - $83,708	856 Added 4.57%	19,597 $1.49 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $13,055 - $16,335	181 Added 0.98%	18,741 $1.66 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $81,433 - $97,905	1,293 Added 7.49%	18,560 $1.41 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $84,096 - $107,494	1,280 Added 8.01%	17,267 $1.26 Million
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $96,887 - $114,032	1,256 Added 8.53%	15,987 $1.29 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $209,727 - $258,650	-2,694 Reduced 15.46%	14,731 $1.36 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $61,170 - $68,001	-688 Reduced 3.8%	17,425 $1.65 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $68,771 - $81,372	-766 Reduced 4.06%	18,113 $1.68 Million
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $6,164 - $8,255	-67 Reduced 0.35%	18,879 $1.79 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $23,016 - $25,239	-257 Reduced 1.34%	18,946 $1.83 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.34 Million - $1.71 Million	19,203	19,203 $1.71 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account